U-Blot® Research Grade NofetumomabCat. No. WA3244Request quote
Size: 50ug/100ug
Overview
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade NofetumomabCat. No. WA3244U-Blot® Research Grade NofazinlimabCat. No. WA3243Request quote
Size: 50ug/100ug
U-Blot® Research Grade NivolumabCat. No. WA3242Request quote
Size: 50ug/100ug
U-Blot® Research Grade nivisnebartCat. No. WA3241Request quote
Size: 50ug/100ug
U-Blot® Research Grade NivatrotamabCat. No. WA3240Request quote
Size: 50ug/100ug
U-Blot® Research Grade NisevokitugCat. No. WA3239Request quote
Size: 50ug/100ug
U-Blot® Research Grade NirsevimabCat. No. WA3238Request quote
Size: 50ug/100ug
U-Blot® Research Grade NipocalimabCat. No. WA3237Request quote
Size: 50ug/100ug
U-Blot® Research Grade NimotuzumabCat. No. WA3236Request quote
Size: 50ug/100ug
U-Blot® Research Grade nilvanstomigCat. No. WA3235Request quote
Size: 50ug/100ug
U-Blot® Research Grade NezutatugCat. No. WA3234Request quote
Size: 50ug/100ug
U-Blot® Research Grade NezastomigCat. No. WA3233Request quote
Size: 50ug/100ug
REQUEST A QUOTE
EMAILinfo@mail.ucallm.com
PHONE+(1)-866-986-9598
ONLINE FORMOnline Quote Submission
X+(1)-866-986-9598